Cargando…

An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives

Profound progress has been made in cancer treatment in the past three decades. However, drug resistance remains prevalent and a critical challenge. Drug resistance can be attributed to oncogenes mutations, activated defensive mechanisms, ATP-bind cassette transporters overexpression, cancer stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Qingmei, Zhou, Xin, Ren, Han, Han, Fangxuan, Lin, Rong, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582727/
https://www.ncbi.nlm.nih.gov/pubmed/37860119
http://dx.doi.org/10.3389/fphar.2023.1274336